期刊文献+

microRNA表达谱与消化器官肿瘤的发生、诊断及治疗 被引量:4

MicroRNA profiles and initiation,diagnosis and treatment of cancers in digestive organs
下载PDF
导出
摘要 microRNA (miRNA)是一种大小约21-23个碱基的、非蛋白编码单链小分子RNA,下调参与许多重要细胞活动(包括发育、增殖、分化、凋亡)基因的表达.近期的研究发现,miRNA在肿瘤的发生和发展中起着重要的作用,miRNA具有癌基因和抑癌基因的作用.已发现若干miRNA直接参与消化器官(包括肝、结肠、胰腺、胃、胆管)肿瘤的发生和发展,miRNA表达谱与消化器官肿瘤的诊断、病理分级、临床分期、疾病进展、预后和对治疗的反应性等相关.miRNA表达谱可以鉴定能抑制下游活化的癌基因信号途径或作用于与肿瘤发生和发展有关的蛋白编码基因的miRNA靶基因,miRNA介导的治疗还可能用于肿瘤的预防和治疗. MicroRNA (miRNA) is a kind of small non-coding RNA containin 21 to 23 nucleotides in length that down-regulates gene expression during various crucial cell processes such as development, proliferation, differentiation and apoptosis. Recent studies supported an important role of miRNA in the initiation and progression of human malignancies. Some miRNAs may function as oncogenes or tumor suppressors. It is found that several miRNAs are directly involved in human cancers of digestive organs, including liver, colon, stomach, pancreas and bile duct. In addition, miRNA expression profiling of tumors in digestive organs has identified signatures associated with diagnosis, staging, progression, prognosis and response to treatment, Profiling has also been exploited to identify miRNA genes that might represent downstream targets of activated oncogenic pathways, or target protein coding genes involved in cancer. Moveover, miRNA-mediated therapy may be a powerful tool for cancer prevention and therapy.
出处 《世界华人消化杂志》 CAS 北大核心 2007年第11期1241-1245,共5页 World Chinese Journal of Digestology
基金 国家杰出青年基金 No.30225038~~
关键词 MICRORNA 表达谱 肿瘤 消化器官 MicroRNA Expression profile Tumor Digestive organ
  • 相关文献

参考文献1

二级参考文献17

  • 1[1]Yeo CJ,Cameron JL,Sohn TA,Lillemoe KD,Pitt HA,Talamini MA,Hruban RH,Ord SE,Sauter PK,Coleman J,Zahurak ML,Grochow LB,Abrams RA.Six hundred fifty consecutive pancr eaticoduodenectomies in the 1990s:pathology,complications,and outcomes.Ann Surg 1997; 226:248-57; discussion 257-260
  • 2[2]Holland EC.Regulation of translation and cancer.Cell Cycle2004; 3:452-455
  • 3[3]Wulfkuhle J,Espina V,Liotta L,Petricoin E.Genomic and proteomic technologies for individualisation and improvement of cancer treatment.Eur J Cancer 2004; 40:2623-2632
  • 4[4]Shalon D,Smith SJ,Brown PO.A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization.Genome Res 1996; 6:639-645
  • 5[5]Jin G,Wang S,Hu X,Jing Z,Chen J,Ying K,Xie Y,Mao Y.Characterization of the tissue-specific expression of the s100P gene which encodes an EF-hand Ca2+-binding protein.Mol Biol Rep 2003; 30:243-248
  • 6[6]van de Vijver MJ,He YD,van't Veer LJ,Dai H,Hart AA,Voskuil DW,Schreiber GJ,Peterse JL,Roberts C,Marton MJ,Parrish M,Atsma D,Witteveen A,Glas A,Delahaye L,van der Velde T,Bartelink H,Rodenhuis S,Rutgers ET,Friend SH,Bernards R.A gene-expression signature as a predictor of survival in breast cancer.N Engl JMed 2002; 347:1999-2009
  • 7[7]Missiaglia E,Blaveri E,Terris B,Wang YH,Costello E,Neoptolemos JP,Crnogorac-Jurcevic T,Lemoine NR.Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis.Int J Cancer 2004; 112:100-112
  • 8[8]Ryu B,Jones J,Blades NJ,Parmigiani G,Hollingsworth MA,Hruban RH,Kern SE.Relationships and differentially expressed genes among pancreatic cancers examined by largescale serial analysis of gene expression.Cancer Res 2002; 62:819-826
  • 9[9]Tarbe N,Losch S,Burtscher H,Jarsch M,Weidle UH.Identification of rat pancreatic carcinoma genes associated with lymphogenous metastasis.Anticancer Res 2002; 22:2015-2027
  • 10[10]Griffin CA,Hruban RH,Morsberger LA,Ellingham T,Long PP,Jaffee EM,Hauda KM,Bohlander SK,Yeo CJ.Consistent chromosome abnormalities in adenocarcinoma of the pancreas.Cancer Res 1995; 55:2394-2399

共引文献1

同被引文献38

  • 1Houbaviy HB,Dennis L,Jaenisch R,et al.Characterization of a highly variable eutherian microRNA gene[J].RNA,2005,11(8):1245-1257.
  • 2Chen C,Ridzon DA,Broomer AJ,et al.,Real-time quantification of microRNAs by stem-loop RT-PCR[J].Nucleic Acids Res,2005,33(20):el79.
  • 3Livak KJ,Schmittgen TD.Analysis of relative gene expression data using Real-Time quantitative PCR and the 2^-△△Ct method[J].Methods,2001,25(4):402-408.
  • 4Esquela-Kerscher A,Slack FJ.Oncomirs-microRNAs with a role in cancer[J].Nat Rev Cancer,2006,6(4):259-269.
  • 5He L,Harmon GJ.Micrornas:small RNAs with a big role in gene regulation[J].Nat Rev Genet,2004,5(7):522-531.
  • 6Ciafre SA,Galardi S,Mangiola A,et al.Extensive modulation of a set of microRNAs in primary glioblastoma[J].Biochem Biophys Res Commun,2005,334(4):1351-1358.
  • 7Visone R,Petrocca F,Croce CM.Micro-RNAs in gastrointestinal and liver disease[J].Gastroenterology,2008,135(6):1866-1869.
  • 8Medina R,Zaidi SK,Liu CG,et al.MicroRNAs 221 and 222 bypass quiescence and compromise cell survival[J].Cancer Res,2008,68(8):2773-2780.
  • 9Poliseno L,Tuccoli A,Mariani L,et al.MicroRNAs modulate the angiogenic properties of HUVECs[J].Blood,2006,108(9):3068-3071.
  • 10Ma Y, Zhang P, Wang F, et al. Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130 [ J]. Nat Commun, 2012,3 : 1291.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部